- Home
- HITI vs FENC Comparison
HITI vs FENC Comparison
Compare HITI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HITI | FENC |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.8M | 258.5M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | HITI | FENC |
|---|---|---|
| Price | $2.82 | $7.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.13 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 734.0K | 189.1K |
| Earning Date | 01-28-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $410,600,094.00 | $38,790,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $29.67 | $70.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.18 | N/A |
| 52 Week Low | $1.64 | $4.68 |
| 52 Week High | $4.06 | $9.92 |
Technical Indicators
Market Signals| Indicator | HITI | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 47.12 |
| Support Level | $2.65 | $7.50 |
| Resistance Level | $3.01 | $7.83 |
| Average True Range (ATR) | 0.17 | 0.28 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 64.81 | 49.23 |
Price Performance
Historical ComparisonAbout HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.